Dr Ian Smith founder and global medical director of Synexus awarded an MBE in the Queen’s New Years honours list
Christophe Berthoux CEO of Synexus commented: "It is an incredible honour for Dr Smith to be recognised in this away. His vision, which became Synexus, was truly inspiring and has changed the way in which the industry recruits patients for, and runs, clinical trials. Synexus has expanded rapidly and has grown to become a positive advocate for science, and its development, here in the UK. Despite the overall trend of decline in clinical trials run in the UK Synexus has continued to increase the number of trials it runs here remaining committed to the quality and value the UK brings to the industry."